Who is sponsoring NCT05645159?

NCT05645159 is sponsored by University of Valencia.

What drugs are being tested in NCT05645159?

Interventions in NCT05645159: Blended learning in heart disease.

What condition does NCT05645159 study?

NCT05645159 studies Heart Diseases, Teach-Back Communication.

Is NCT05645159 still recruiting?

NCT05645159 is currently completed. Last updated 19 April 2023.

Last reviewed 2023-04-19 · How we verify

NCT05645159

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Blended Learning in Future Physiotherapy Professionals

Completed NA Last updated 19 April 2023

What this trial tests

NA trial testing Blended learning in heart disease in Heart Diseases in 124 participants. Completed in 30 June 2021.

Timeline

1 January 2021

Primary endpoint
28 February 2021

30 June 2021

Quick facts

Lead sponsor	University of Valencia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	124
Start date	1 January 2021
Primary completion	28 February 2021
Estimated completion	30 June 2021
Sites	1 location across Spain

Drugs / interventions tested

Blended learning in heart disease

Conditions studied

Heart Diseases — all drugs for Heart Diseases →
Teach-Back Communication — all drugs for Teach-Back Communication →

Sponsor

University of Valencia

Who can join

Adults 18 to 35, any sex, with Heart Diseases or Teach-Back Communication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Blended Learning (BL) is proving to be an effective method of teaching within the health professions . However, there are still scarce studies on BL conducted with undergraduate physiotherapy students. Therefore, the aim of this study was to determine the effectiveness of a heart disease BL programme in knowledge, motivation, engagement, design of the programme instructions and learning behaviours in physiotherapy students.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effectiveness of a heart disease blended learning program in physiotherapy students: a prospective study.
Marques-Sule E, Hernández-Guillén D, Cezón-Serrano N, Arjona-Tinaut L, et al · · 2023 · cited 2× · PMID 38075964 · DOI 10.3389/fcvm.2023.1303997

Verify or expand the search:

Other recruiting trials for Heart Diseases

Currently open trials in the same condition.

NCT07288216 — Transition to KPL-387 Monotherapy Dosing & Administration Study · Phase 2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
NCT06954610 — Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation · recruiting
NCT06769880 — Use of Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Fa · NA · recruiting

Other University of Valencia trials

Trials by the same sponsor.

NCT07509281 — Peri-implant Tissues Changes for Different Abutment Shapes and Heights · NA · not yet recruiting
NCT07535528 — Implant Placement Depth and Peri-Implant Tissue Outcomes · NA · not yet recruiting
NCT07471555 — Vascular Access and Intraosseus · NA · enrolling by invitation
NCT07463066 — Long-Term Effectiveness of Pain Neuroscience Education in Women With Genito-Pelvic Pain/Penetration Disorder. · not yet recruiting
NCT07419399 — Acute Effects of Radiofrequency Diathermy in Postpartum Women With Diastasis Abdominis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05645159 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Valencia
Last refreshed: 19 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05645159.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing